Eucalyptus vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Eucalyptus is Australia's largest digital health company with US$450M+ ARR and triple-digit quarterly growth; operates Juniper, Pilot, Software, and Kin clinics; agreed acquisition by Hims & Hers for up to $1.15B in 2026.
About
Eucalyptus is an Australian digital health company founded in 2019 by Tim Doyle, Benny Kleist, Alexey Mitko, and Charlie Gearside. The company operates a portfolio of specialized telehealth brands spanning key consumer health categories: Juniper (women''s weight management and menopause), Pilot (men''s health including hair loss and erectile dysfunction), Software (dermatology and skincare), and Kin (reproductive health and fertility). Each brand operates as a distinct consumer-facing clinic with its own branding, medical teams, and care protocols, while sharing Eucalyptus''s underlying technology, regulatory, and clinical infrastructure.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.